|
UR8000 Coagulation Analyzer – High-Throughput Automated Hemostasis Testing System
Central hospital labs processing hundreds of coagulation samples daily face a bottleneck: throughput. The UR8000, a fully automated hemostasis analyzer from Chinese diagnostics firm SunBio, addresses this with a 900-test-per-hour platform that integrates multiple assay types into a single workflow.
The system is built around 40 detection channels that run coagulation, immunoturbidimetric, and chromogenic assays simultaneously. This allows a single instrument to handle PT, APTT, FIB, TT, and D-Dimer panels — the core tests for surgical screening, anticoagulant monitoring, and bleeding disorder diagnosis — without reconfiguration.
Operationally, the UR8000 removes friction through intelligent sample pre-screening: it automatically flags hemolysis, icterus, and lipemia before analysis, reducing repeat draws and manual review. Closed-tube sampling with cap-piercing and barcode tracking cuts biohazard exposure and specimen handling errors.
For lab managers, the real value is uptime. Large-capacity reagent and cuvette trays support extended runs, and the system’s compatibility with track-based lab automation lines means it can scale with consolidation trends in Chinese hospital networks.
SunBio’s positioning is notable: rather than competing purely on price, the UR8000 targets performance parity with established Japanese and European hemostasis platforms. Its multi-method, high-throughput architecture reflects a deliberate investment in R&D depth by a domestic supplier.
The broader signal is that China’s in vitro diagnostics industry has moved beyond copycat assembly. The UR8000 competes on specs — 900 tests per hour, 40 channels, automated interference detection — that once defined only premium imports.
In a procurement environment that increasingly weighs total cost of ownership alongside feature parity, the UR8000 offers a credible alternative that stretches budget allocations without compromising throughput.
Why it matters:
For labs managing 200+ daily coagulation tests, the UR8000 eliminates the need for multiple dedicated analyzers. Its closed automation and multi-assay capability reduce staffing demands and error rates, while the domestic price point makes advanced hemostasis capacity accessible to tier-2 and tier-3 hospitals.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.